Cardinal Point Capital Management ULC acquired a new position in Amrize Ltd (NYSE:AMRZ – Free Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 46,185 shares of the company’s stock, valued at approximately $2,228,000.
Other large investors have also made changes to their positions in the company. State of Wyoming acquired a new stake in Amrize in the 3rd quarter valued at approximately $32,000. Global Retirement Partners LLC bought a new stake in shares of Amrize in the third quarter valued at approximately $48,000. Jones Financial Companies Lllp acquired a new stake in shares of Amrize in the third quarter worth $53,000. BNP Paribas Financial Markets bought a new position in Amrize during the second quarter worth $59,000. Finally, Groupe la Francaise acquired a new position in Amrize during the 2nd quarter valued at $60,000.
Wall Street Analyst Weigh In
Several analysts have issued reports on AMRZ shares. Sanford C. Bernstein restated an “outperform” rating and issued a $70.00 price target on shares of Amrize in a research report on Thursday, December 18th. Stephens began coverage on shares of Amrize in a research note on Friday, November 14th. They issued an “overweight” rating and a $60.00 target price for the company. Royal Bank Of Canada lowered Amrize from an “outperform” rating to a “sector perform” rating and boosted their price target for the company from $56.00 to $60.00 in a research note on Monday, December 8th. Wells Fargo & Company upped their price target on Amrize from $58.00 to $59.00 and gave the company an “overweight” rating in a report on Thursday, January 29th. Finally, Citigroup raised their price objective on Amrize from $63.00 to $67.00 and gave the stock a “buy” rating in a research report on Thursday, January 8th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat.com, Amrize presently has a consensus rating of “Moderate Buy” and a consensus price target of $60.75.
Amrize Stock Performance
NYSE AMRZ opened at $58.39 on Monday. Amrize Ltd has a twelve month low of $44.12 and a twelve month high of $58.47. The company has a quick ratio of 0.97, a current ratio of 1.45 and a debt-to-equity ratio of 0.38. The stock has a market cap of $32.29 billion and a P/E ratio of 31.73. The company’s 50-day simple moving average is $54.74 and its 200 day simple moving average is $51.86.
Insiders Place Their Bets
In related news, Director Nicholas C. Gangestad acquired 2,000 shares of the stock in a transaction dated Wednesday, November 19th. The shares were bought at an average cost of $47.34 per share, for a total transaction of $94,680.00. Following the purchase, the director owned 4,958 shares in the company, valued at approximately $234,711.72. This trade represents a 67.61% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
Amrize Profile
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
See Also
- Five stocks we like better than Amrize
- Your Bank Account Is No Longer Safe
- The day the gold market broke
- What a Former CIA Agent Knows About the Coming Collapse
- He just nailed another gold prediction …
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ – Free Report).
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
